STAT3 and metastatic malignant neoplasm in the lymph nodes: The results showed significantly lower STAT3/p-STAT3 expression in lymphatic metastasis patients than in those without lymph node metastasis (OR = 3.39, 95% CI = 2.39–4.81, p < 0.00001).